Glycogen synthase kinase 3 (GSK3) inhibitor, SB-216763, promotes pluripotency in mouse embryonic stem cells.
Canonical Wnt/β-catenin signaling has been suggested to promote self-renewal of pluripotent mouse and human embryonic stem cells. Here, we show that SB-216763, a glycogen synthase kinase-3 (GSK3) inhibitor, can maintain mouse embryonic stem cells (mESCs) in a pluripotent state in the absence of exog...
Main Authors: | Leslie A Kirby, Jason T Schott, Brenda L Noble, Daniel C Mendez, Paul S Caseley, Sarah C Peterson, Tyler J Routledge, Nilay V Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3383737?pdf=render |
Similar Items
-
Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
by: Jing Zhang, et al.
Published: (2021-01-01) -
Corrigendum: Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
Published: (2021-01-01) -
Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
by: Xian-Cang Ma, et al.
Published: (2013-01-01) -
Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
by: Pamela R. Westmark, et al.
Published: (2021-10-01) -
SB216763, a selective small molecule inhibitor of glycogen synthase kinase-3, improves bleomycin-induced pulmonary fibrosis via activating autophagy
by: Hong Liu, et al.
Published: (2013-07-01)